Research output

No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • CYP2D6, severe mental illness (SMI), guidelines, dose adjustment, genotyping, psychopharmacology, personalized medicine, CURACAO EXTRAPYRAMIDAL SYNDROMES, TARDIVE-DYSKINESIA, RATING-SCALE, PERSONALIZED MEDICINE, INDUCED AKATHISIA, SCHIZOPHRENIA, PHARMACOGENETICS, ANTIPSYCHOTICS, 2D6, POLYMORPHISMS
View graph of relations

Details

Original languageEnglish
Article number349
Number of pages9
JournalFrontiers in Psychiatry
Volume9
DOIs
Publication statusPublished - 7 Aug 2018